Bank of Montreal’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,102
Closed -$156K 4133
2024
Q2
$156K Buy
+14,102
New +$155K ﹤0.01% 3097
2023
Q2
Sell
-28,055
Closed -$411K 4210
2023
Q1
$411K Buy
+28,055
New +$469K ﹤0.01% 2574
2022
Q1
Sell
-4,641
Closed -$285K 4253
2021
Q4
$285K Buy
+4,641
New +$352K ﹤0.01% 2754
2021
Q2
Sell
-478
Closed -$24K 4568
2021
Q1
$24K Sell
478
-1,840
-79% -$88.8K ﹤0.01% 3983
2020
Q4
$89K Buy
2,318
+1,643
+243% +$40.2K ﹤0.01% 3650
2020
Q3
$14K Sell
675
-461
-41% -$7.91K ﹤0.01% 3989
2020
Q2
$16K Buy
+1,136
New +$12.3K ﹤0.01% 3954
2020
Q1
Sell
-1,714
Closed -$18K 4526
2019
Q4
$18K Sell
1,714
-12,259
-88% -$139K ﹤0.01% 4369
2019
Q3
$203K Buy
13,973
+12,973
+1,297% +$201K ﹤0.01% 2896
2019
Q2
$16K Buy
+1,000
New +$13.5K ﹤0.01% 4306

Other funds holding OPRX

Bank of Montreal's OPRX Position: Q3 2024 in Review

Bank of Montreal sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 14,102 shares — an estimated $156K sold.

Bank of Montreal first reported a position in OPRX in Q2 2019 and held it in 10 quarters. The position peaked at $411K in Q1 2023. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

  • Bank of Montreal reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 14,102 OptimizeRx shares in Q3 2024, an estimated $156K.
  • Bank of Montreal first reported a position in OptimizeRx in Q2 2019 and held it in 10 quarters.
  • Bank of Montreal's OptimizeRx position peaked at $411K in Q1 2023.
  • 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.